So it was a $3.5M difference to the prior year. So decrease in profit was still substantial.
20.9M + $3.5M = 24.4M NPAT adjusted for unvested performance rights
20.9M was a 16% decline in NPAT and still it was 13.3% decline in NPAT when adjusted for unvested performance rights.
Linear? That's a bit of BS "cough cough." Easy to skim over if you don't bother doing the calculations and to take that as truth.
Please do correct me if my calculations are wrong.
Not too worried considering covid history and impact. BUT...I am concerned about the competition that is on the rise though. I'm not sure how this will impact them moving forward once they are fully approved. Does anyone have an opinion in the competition being an issue? I assume it will be because it will take away some market share, when CUV actually has a bit of a monopoly at present. That moat may be broken in future?
So it was a $3.5M difference to the prior year. So decrease in...
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.37 |
Change
0.130(0.85%) |
Mkt cap ! $770.0M | |||
| Open | High | Low | Value | Volume |
| $15.36 | $15.54 | $15.18 | $1.274M | 82.63K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 237 | $15.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.50 | 282 | 2 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| CUV (ASX) Chart |